US Stock MarketDetailed Quotes
ALVO Alvotech
- 12.400
- -0.100-0.80%
Close Oct 16 16:00 ET
3.74BMarket Cap-4679P/E (TTM)
12.550High12.295Low116.94KVolume12.540Open12.500Pre Close1.45MTurnover0.11%Turnover RatioLossP/E (Static)301.94MShares18.00052wk High-6.18P/B1.33BFloat Cap8.30052wk Low--Dividend TTM106.87MShs Float18.000Historical High--Div YieldTTM2.04%Amplitude5.200Historical Low12.413Avg Price1Lot Size
About Alvotech Company
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Company Profile
SymbolALVO
Company NameAlvotech
Listing DateJun 16, 2022
Founded2013
CEOMr. Robert Wessman
MarketNASDAQ
Employees999
Fiscal Year Ends12-31
Address9, rue de Bitbourg
CityLuxembourg
ProvinceLuxembourg
CountryLuxembourg
Zip Code1273
Phone352-422-4500
Websitehttp://www.alvotech.com
Company Executives
- Name
- Position
- Salary
- Robert Wessman
- Chairman of the Board and Chief Executive Officer
- --
- Joseph E. McClellan
- Chief Scientific Officer
- --
- Joel Morales
- Chief Financial Officer
- --
- Richard Davies
- Deputy Chairman of the Board
- --
- Arni Hardarson
- Director
- --
- Ann Merchant
- Director
- --
- Faysal Kalmoua
- Director
- --
- Linda McGoldrick
- Director
- --
- Lisa Graver
- Director
- --
- Tomas Ekman
- Director
- --
- Tanya Zharov
- General Counsel
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data